C05.SI Chemical Ind (Far East) SES +9.57% to S$0.515 pre Feb 2026: rising vol

C05.SI stock jumped 9.57% to S$0.515 in pre-market trading on 10 Feb 2026 on a volume surge to 6,100 shares, marking a relative volume of 3.25x versus the 50-day average. The move came ahead of any earnings release and follows a recent run from the previous close of S$0.47. We review why volume picked up, what the latest ratios imply, and how traders might frame short-term risk in the SES (Singapore) session. Meyka AI’s platform flagged the name as a high-volume mover for pre-market traders and market watchers.

C05.SI stock pre-market snapshot and trading flow

C05.SI stock is trading on the SES (Singapore) exchange at S$0.515 after opening at S$0.50, with a day range of S$0.50–S$0.515. Market cap stands at S$39.11M and shares outstanding are 75,945,399. Volume of 6,100 today compares with an average volume of 1,876, signalling short-term trader interest and higher liquidity for a small-cap chemical name.

Why volume spiked: catalysts and market context

There is no scheduled earnings announcement, so the jump appears driven by order flow and momentum. The Basic Materials chemicals peer group has mixed performance, while smaller industrial names have shown renewed investor interest this week. Short-term momentum indicators and a low float often amplify moves in small caps, and C05.SI’s relVolume 3.25 suggests concentrated buying.

Fundamentals, valuation and C05.SI stock metrics

Chemical Industries (Far East) Limited (C05.SI) reports trailing EPS of -0.31 and a negative PE of -1.66, reflecting recent net losses. The stock trades at a PB ratio 0.35 with book value per share S$1.46, implying deep asset backing versus price. Free cash flow per share is S$0.03 and current ratio is 1.85, signalling adequate short-term liquidity for operations.

Meyka AI rates C05.SI with a score out of 100

Meyka AI rates C05.SI with a score of 59.67 out of 100 (Grade C+, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade signals neutral sentiment relative to peers while recognising a strong price-to-book value but weak profitability and negative EPS.

Technicals, short-term levels and price action

Technicals show the 50-day average at S$0.52 and 200-day average at S$0.53, keeping the current price near short-term averages. RSI sits around 45.45, indicating neither overbought nor oversold conditions. Key levels: support S$0.50 (today’s low) and resistance S$0.59 (52-week high); a sustained break above S$0.52 with volume could extend the run.

Analyst view, forecast and practical price targets

Meyka AI’s forecast model projects a quarterly target S$0.40 and a monthly target S$0.43, reflecting conservative short-term outlook versus the current S$0.515. Using these, the implied move is a downside of -22.33% to S$0.40 and -16.50% to S$0.43. For scenario planning, analysts looking at assets and PB ratio may set a fair-value recovery target near S$0.60, a +16.50% upside from current levels.

Final Thoughts

Key takeaways: C05.SI stock rose 9.57% pre-market to S$0.515 on 10 Feb 2026 on a clear volume uptick to 6,100 shares, marking it as a high-volume mover on the SES (Singapore) session. Fundamentals show a low PB of 0.35 and book value S$1.46, but earnings remain negative with EPS -0.31 and PE -1.66, which raises profit concerns. Meyka AI’s forecast model projects a short-term quarterly target of S$0.40, implying -22.33% downside versus current price; alternate valuation scenarios place a recovery/price target at S$0.60 (+16.50%). Traders should watch intraday volume and the S$0.52–S$0.59 band for confirmation. Our analysis uses public filings and market data and is delivered by Meyka AI as an AI-powered market analysis platform; forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.